For those who don’t remember the case, the context here is the RBI action to write down Yes Bank’s AT1 bonds as part of a rescue plan. A stock exchange clarification from Yes Bank’s RBI-appointed administrator, Prashant Kumar, in March said the AT1 bondholders will get nothing as per the condition of the reconstruction scheme. This, logically, came as a jolt to many investors, both retail and institutional. … [Read more...] about Banking Central: RBI ko gussa kyon aata hai?
Why do governments regulate banks
Between Rossari Biotech, Yes Bank FPO, and Bharat Bond ETF, if we take a long-term view and moderate to high-risk profile, we like Rossari the most, given that it ticks the right boxes when it comes to sector and growth profile. At the offer price, Rossari would be valued at a premium relative to some of its larger peers (P/E of around 36) like Vinati, Atul, and Fine Organics. This valuation could be justified given its higher revenue and net income CAGR numbers. … [Read more...] about Rossari Biotech IPO, Bharat Bond ETF & Yes Bank FPO: Where should investors put their money?
Another official said low realisation is a critical issue for some subsidiaries but the problem is short lived. "Subsidiaries had been asked to rely on short-term loans from banks. Coal India does not have any plan for long-term borrowing through instruments like issuing bonds to tide over this crisis," he said. … [Read more...] about Coal India dues from state power gencos mount to Rs 22,000 crore amid tepid demand
That AAP was born in 2011 and a beneficiary of the Anna Hazare-led anti-corruption movement is no longer its USP. Neither is AAP’s dramatic re-capture of Delhi in 2015 by winning 67 of the 70 assembly seats. The reality is that, today, AAP is plagued by internal dissensions and accusations of corruption; it is anything but what it was in 2011. On top of this, the party was ready to join hands with the Congress — the same party it opposed for its corruption and misgovernance. … [Read more...] about Politics | Has BJP taken the winds out of AAP’s and Congress’ sails?
As on May 31, 2020, Rossari Biotech had a range of 2,030 different products sold across these categories. The company manufactures majority of its products in-house from their manufacturing facility at Silvassa (which has 1.2 lakh MTPA capacity) and currently it is setting up another manufacturing facility at Dahej in Gujarat with a proposed installed capacity of 1,32,500 MTPA. … [Read more...] about Rossari Biotech IPO opens today, subscribed 34% so far on Day 1